Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jun 1;87(2):e198-e206.
doi: 10.1097/QAI.0000000000002634.

Development, Assessment, and Outcomes of a Community-Based Model of Antiretroviral Care in Western Kenya Through a Cluster-Randomized Control Trial

Suzanne Goodrich  1 , Abraham Siika  2 , Ann Mwangi  3 , Monicah Nyambura  4 , Violet Naanyu  3 , Constantin Yiannoutsos  5 , Thomas Spira  6 , Moses Bateganya  6 , Cathy Toroitich-Ruto  7 , Boaz Otieno-Nyunya  7 , Kara Wools-Kaloustian  1
Affiliations
Randomized Controlled Trial

Development, Assessment, and Outcomes of a Community-Based Model of Antiretroviral Care in Western Kenya Through a Cluster-Randomized Control Trial

Suzanne Goodrich et al. J Acquir Immune Defic Syndr. .

Abstract

Objective: To develop and assess an alternative care model using community-based groups for people living with HIV and facilitate by lay personnel.

Methods: Geographic locations in the Academic Model Providing Access to Healthcare Kitale clinic catchment were randomized to standard of care versus a community-based care group (ART Co-op). Adults stable on antiretroviral therapy and virally suppressed were eligible. Research Assistant-led ART Co-ops met in the community every 3 months. Participants were seen in the HIV clinic only if referred. CD4 count and viral load were measured in clinic at enrollment and after 12 months. Retention, viral suppression, and clinic utilization were compared between groups using χ2, Fisher exact, and Wilcoxon rank sum tests.

Results: At 12 months, there were no significant differences in mean CD4 count or viral load suppression. There was a significant difference in patient retention in assigned study group between the intervention and control group (81.6% vs 98.6%; P < 0.001), with a number of intervention patients withdrawing because of stigma, relocation, pregnancy, and work conflicts. All participants, however, were retained in an HIV care program for the study duration. The median number of clinic visits was lower for the intervention group than that for the control group (0 vs 3; P < 0.001).

Conclusions: Individuals retained in a community-based HIV care model had clinical outcomes equivalent to those receiving clinic-based care. This innovative model of HIV care addresses the problems of insufficient health care personnel and patient retention barriers, including time, distance, and cost to attend clinic, and has the potential for wider implementation.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Enrollment cascade.
See this image and copyright information in PMC

References

    1. UNAIDS. Global HIV and AIDS Statistics–2020 Fact Sheet. Available at: https://www.unaids.org/en/resources/fact-sheet. Accessed November 14, 2020.
    1. HIV.gov. The Global HIV/AIDS Epidemic. Available at: https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics. Accessed November 12, 2020.
    1. UNAIDS. Kenya. Available at: http://www.unaids.org/en/regionscountries/countries/kenya. Accessed August 10, 2020.
    1. World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV. 2015. Available at: https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/. Accessed August 10, 2020. - PubMed
    1. UNAIDS. 90-90-90- an Ambitious Treatment Target to Help End the AIDS Epidemic. Available at: https://www.unaids.org/en/resources/documents/2017/90-90-90. Accessed on January 1, 2017.

Publication types

Substances